Provided by Tiger Trade Technology Pte. Ltd.

Xenetic Biosciences Inc

2.40
-0.0630-2.56%
Post-market: 2.400.00000.00%19:32 EST
Volume:82.50K
Turnover:195.92K
Market Cap:5.50M
PE:-1.17
High:2.64
Open:2.64
Low:2.31
Close:2.46
52wk High:13.93
52wk Low:2.20
Shares:2.29M
Float Shares:1.92M
Volume Ratio:2.87
T/O Rate:4.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0467
EPS(LYR):-2.5694
ROE:-57.43%
ROA:-31.56%
PB:1.39
PE(LYR):-0.93

Loading ...

Company Profile

Company Name:
Xenetic Biosciences Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
2
Office Location:
945 Concord Street,Framingham,Massachusetts,United States
Zip Code:
01701
Fax:
- -
Introduction:
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Directors

Name
Position
Dmitry Genkin
Chairman
Alexey Vinogradov
Independent Director
Firdaus Jal Dastoor
Independent Director
Grigory Borisenko
Independent Director
Roger Kornberg
Independent Director
Moshe Mizrahy
Director

Shareholders

Name
Position
James Parslow
Interim Chief Executive Officer, Chief Financial Officer and Corporate Secretary